Gabriele TUDERTI
Papers
1
Total Citations
10
H-Index
1
About
Gabriele Tuderti is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for upper urinary tract malignancies, particularly through robotic-assisted approaches. His major contributions center on kidney-sparing surgery for high-risk urothelial carcinoma, challenging traditional paradigms that favored radical nephroureterectomy. As a key member of the ROBUUST 2.0 collaborative group, Tuderti co-authored the landmark 2024 study "Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma," which provided the first multicenter comparative analysis demonstrating that robot-assisted distal ureterectomy can achieve oncological outcomes comparable to radical surgery while preserving renal function in carefully selected high-risk patients. This work, already garnering 10 citations within its first year, addresses a critical controversy in urologic oncology. Tuderti’s research has significant clinical impact, offering patients with high-risk distal ureteral tumors a viable kidney-sparing alternative that reduces long-term morbidity from chronic kidney disease. His contributions are shaping evidence-based guidelines and expanding the role of robotic surgery in complex urothelial cancer management, establishing him as an emerging authority in reconstructive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1